{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:30:23Z","timestamp":1788561023534,"version":"build-2803163510"},"reference-count":75,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S026088\/1"],"award-info":[{"award-number":["MR\/S026088\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2023,3,29]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>Autoimmune neuromuscular diseases are common and often treatable causes for peripheral nervous system dysfunction. If not optimally managed, they result in meaningful impairments and disability. The treating neurologist should aim to maximise clinical recovery with minimal iatrogenic risk. This requires careful patient and medication selection, appropriate counselling and close monitoring of clinical efficacy and safety. Here, we summarise our consensus departmental approach to first-line immunosuppression in neuromuscular diseases. We combine multispecialty evidence and expertise with a focus on autoimmune neuromuscular diseases to create guidance on starting, dosing and monitoring for toxic effects of the commonly used drugs. These include corticosteroids, steroid-sparing agents and cyclophosphamide. We also provide efficacy monitoring advice, as clinical response informs dosage and drug choice. The principles of this approach could be applied across much of the spectrum of immune-mediated neurological disorders where there is significant therapeutic crossover.<\/jats:p>","DOI":"10.1136\/pn-2023-003708","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T13:24:42Z","timestamp":1683897882000},"page":"327-338","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["First-line immunosuppression in neuromuscular diseases"],"prefix":"10.1136","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7201-7475","authenticated-orcid":false,"given":"Michael A","family":"Foster","sequence":"first","affiliation":[{"name":"UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK"},{"name":"Division of Neurology, National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3174-6027","authenticated-orcid":false,"given":"Michael PT","family":"Lunn","sequence":"additional","affiliation":[{"name":"UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK"},{"name":"Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling S","family":"Carr","sequence":"additional","affiliation":[{"name":"UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK"},{"name":"Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"2025090409241954000_23.4.327.1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-018-0027-2","article-title":"Immune-Mediated neuropathies","volume":"4","author":"Kieseier","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025090409241954000_23.4.327.2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63432-0.00024-4"},{"key":"2025090409241954000_23.4.327.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0"},{"key":"2025090409241954000_23.4.327.4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314862"},{"key":"2025090409241954000_23.4.327.5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-320314"},{"key":"2025090409241954000_23.4.327.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.011"},{"key":"2025090409241954000_23.4.327.7","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2018-001899"},{"key":"2025090409241954000_23.4.327.8","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2018-002161"},{"key":"2025090409241954000_23.4.327.9","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2019-002336"},{"key":"2025090409241954000_23.4.327.10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1474-7766.2002.00302.x","article-title":"Myositis diagnosis and management","volume":"2","author":"Chevrel","year":"2002","journal-title":"Pract Neurol"},{"key":"2025090409241954000_23.4.327.11","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2021-002991"},{"key":"2025090409241954000_23.4.327.12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1474-7766.2002.00091.x","article-title":"Multifocal motor neuropathy","volume":"2","author":"Willison","year":"2002","journal-title":"Pract Neurol"},{"key":"2025090409241954000_23.4.327.13","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2012-000464"},{"key":"2025090409241954000_23.4.327.14","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2015-001126"},{"key":"2025090409241954000_23.4.327.15","unstructured":"GMC . Guidance on professional standards and ethics for doctors: decision making and consent. 2020. Available: www.gmc-uk.org\/guidance"},{"key":"2025090409241954000_23.4.327.16","unstructured":"WHO . International drug monitoring: the role of national centres. Report of a who meeting. Geneva, 1972."},{"key":"2025090409241954000_23.4.327.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39609.449676.25"},{"key":"2025090409241954000_23.4.327.18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew479"},{"key":"2025090409241954000_23.4.327.19","unstructured":"Centers for Disease Control and Prevention . Latent tuberculosis infection: a guide for primary health care providers; 2020."},{"key":"2025090409241954000_23.4.327.20","doi-asserted-by":"publisher","DOI":"10.1086\/526778"},{"key":"2025090409241954000_23.4.327.21","doi-asserted-by":"publisher","DOI":"10.4065\/71.1.5"},{"key":"2025090409241954000_23.4.327.22","doi-asserted-by":"crossref","unstructured":"G\u00f8tzsche PC , Johansen HK , Cochrane Musculoskeletal Group . Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Cochrane Database Syst Rev 2005. doi:10.1002\/14651858.CD000189.pub2","DOI":"10.1002\/14651858.CD000189.pub2"},{"key":"2025090409241954000_23.4.327.23","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","volume":"2014","author":"Stern","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090409241954000_23.4.327.24","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12599"},{"key":"2025090409241954000_23.4.327.25","first-page":"795","article-title":"Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener\u2019s granulomatosis","volume":"151","author":"Ognibene","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2025090409241954000_23.4.327.26","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.4.770-782.2004"},{"key":"2025090409241954000_23.4.327.27","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151043"},{"key":"2025090409241954000_23.4.327.28","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-4-42","article-title":"Autoimmune inflammatory disorders, systemic corticosteroids and Pneumocystis pneumonia: a strategy for prevention","volume":"4","author":"Sowden","year":"2004","journal-title":"BMC Infect Dis"},{"key":"2025090409241954000_23.4.327.29","doi-asserted-by":"publisher","DOI":"10.3201\/eid1010.030994"},{"key":"2025090409241954000_23.4.327.30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.12.1383"},{"key":"2025090409241954000_23.4.327.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2009.01.373"},{"key":"2025090409241954000_23.4.327.32","unstructured":"National Osteoporosis Guideline Group . Available: https:\/\/www.nogg.org.uk\/full-guideline [Accessed 17 Jan 2023]."},{"key":"2025090409241954000_23.4.327.33","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00198-015-3176-0","article-title":"FRAX-based assessment and intervention thresholds -- an exploration of thresholds in women aged 50 years and older in the UK","volume":"26","author":"McCloskey","year":"2015","journal-title":"Osteoporos Int"},{"key":"2025090409241954000_23.4.327.34","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-10-200605160-00009"},{"key":"2025090409241954000_23.4.327.35","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1093\/rheumatology\/keac552","article-title":"British Society for rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice","volume":"62","author":"Schreiber","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025090409241954000_23.4.327.36","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.072157"},{"key":"2025090409241954000_23.4.327.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)80043-9"},{"key":"2025090409241954000_23.4.327.38","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","article-title":"British Society for rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell","year":"2023","journal-title":"Rheumatology"},{"key":"2025090409241954000_23.4.327.39","unstructured":"MHRA . Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients. Drug Safety Update 2018;11."},{"key":"2025090409241954000_23.4.327.40","unstructured":"Public Health England . Chapter 7: immunisation of immunocompromised individuals. In: Immunisation against infectious disease. 2020."},{"key":"2025090409241954000_23.4.327.41","unstructured":"Public Health England . Chapter 19: influenza. In: Immunisation against infectious disease. 2020."},{"key":"2025090409241954000_23.4.327.42","unstructured":"Public Health England . Chapter 25: pneumoccocal. In: Immunisation against infectious disease. 2020."},{"key":"2025090409241954000_23.4.327.43","unstructured":"Public Health England . Updated guidelines on post exposure prophylaxis (PEP) for varicella\/shingles; 2019."},{"key":"2025090409241954000_23.4.327.44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ALN.0000000000001659","article-title":"Perioperative steroid management: approaches based on current evidence","volume":"127","author":"Liu","year":"2017","journal-title":"Anesthesiology"},{"key":"2025090409241954000_23.4.327.45","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2022-003438"},{"key":"2025090409241954000_23.4.327.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.06.006"},{"key":"2025090409241954000_23.4.327.47","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90233-9"},{"key":"2025090409241954000_23.4.327.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197908023010503"},{"key":"2025090409241954000_23.4.327.49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2010.00281.x"},{"key":"2025090409241954000_23.4.327.50","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket445"},{"key":"2025090409241954000_23.4.327.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020286"},{"key":"2025090409241954000_23.4.327.52","doi-asserted-by":"publisher","DOI":"10.1002\/art.21142"},{"key":"2025090409241954000_23.4.327.53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1658"},{"key":"2025090409241954000_23.4.327.54","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw211"},{"key":"2025090409241954000_23.4.327.55","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211123"},{"key":"2025090409241954000_23.4.327.56","doi-asserted-by":"crossref","DOI":"10.7326\/L20-1199","article-title":"Long-term rituximab use to maintain remission of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"173","author":"Charles","year":"2020","journal-title":"Ann Intern Med"},{"key":"2025090409241954000_23.4.327.57","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230202"},{"key":"2025090409241954000_23.4.327.58","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880141111"},{"key":"2025090409241954000_23.4.327.59","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ene.13025","article-title":"Correlation of the patient\u2019s reported outcome inflammatory-RODS with an objective metric in immune-mediated neuropathies","volume":"23","author":"Draak","year":"2016","journal-title":"Eur J Neurol"},{"key":"2025090409241954000_23.4.327.60","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001044"},{"key":"2025090409241954000_23.4.327.61","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1468-1331.2012.03851.x","article-title":"Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIg -- the ice study","volume":"20","author":"Vanhoutte","year":"2013","journal-title":"Eur J Neurol"},{"key":"2025090409241954000_23.4.327.62","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008321","article-title":"Inter-rater reliability of the Berg balance scale, 30 S chair stand test and 6 M walking test, and construct validity of the Berg balance scale in nursing home residents with mild-to-moderate dementia","volume":"5","author":"Telenius","year":"2015","journal-title":"BMJ Open"},{"key":"2025090409241954000_23.4.327.63","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.081547"},{"key":"2025090409241954000_23.4.327.64","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1212\/WNL.54.4.943","article-title":"Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies","volume":"54","author":"Merkies","year":"2000","journal-title":"Neurology"},{"key":"2025090409241954000_23.4.327.65","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/50A.1.M28"},{"key":"2025090409241954000_23.4.327.66","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25162"},{"key":"2025090409241954000_23.4.327.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2005.07.002"},{"key":"2025090409241954000_23.4.327.68","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/jns.12141","article-title":"rasch-built overall disability scale for multifocal motor neuropathy (MMN-RODS \u00a9)","volume":"20","author":"Vanhoutte","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"2025090409241954000_23.4.327.69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1991.tb01616.x"},{"key":"2025090409241954000_23.4.327.70","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401109"},{"key":"2025090409241954000_23.4.327.71","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20035","article-title":"Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies","volume":"62","author":"Rider","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090409241954000_23.4.327.72","doi-asserted-by":"publisher","DOI":"10.1002\/art.23963"},{"key":"2025090409241954000_23.4.327.73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JND-150082","article-title":"Psychometric properties of the quantitative myasthenia gravis score and the myasthenia gravis composite scale","volume":"2","author":"Barnett","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"2025090409241954000_23.4.327.74","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22140"},{"key":"2025090409241954000_23.4.327.75","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14963"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/pn-2023-003708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T16:24:40Z","timestamp":1757003080000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/pn-2023-003708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":75,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,7,28]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/pn-2023-003708"],"URL":"https:\/\/doi.org\/10.1136\/pn-2023-003708","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]}}}